Seigo Izumo, MD Joins Gilead Sciences, Inc. as Senior Vice President, Cardiovascular Therapeutics

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Seigo Izumo, MD has joined the company as Senior Vice President, Cardiovascular Therapeutics. Dr. Izumo will report to Norbert Bischofberger, PhD, Gilead’s Executive Vice President, Research and Development and Chief Scientific Officer. Dr. Izumo will oversee Gilead’s growing cardiovascular business unit and will serve as a member of Gilead’s executive committee.

Back to news